Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375959 · ClinicalTrials.gov registry record · NA
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT01375959 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 38 participants.
The verdict
NCT01375959, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Resveratrol is a substance found in many plants, including grapes and red wine, which is widely used as a nutritional supplement. Studies in cells and lower animals show that resveratrol has many potential benefits, including prolonging lifespan, preventing cancer and heart disease and normalization of glucose metabolism. Although use of this agent shows great promise in the treatment and/or prevention of diabetes, there have been no studies reported to date in humans. As an initial step, this proposal is for a 6 week pilot study of resveratrol treatment in older adults with impaired glucose tolerance (IGT) in order to explore its effects on post-meal blood glucose metabolism. Preliminary studies will also be conducted to explore how resveratrol works by studying cellular function (in muscle samples obtained from study participants) and by testing resveratrol's effect on blood vessel function.
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT resveratrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2011-04 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01375959
The ClinicalTrials.gov registry entry for NCT01375959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01375959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01375959 about?
NCT01375959 is a clinical study titled "Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance". Resveratrol is a substance found in many plants, including grapes and red wine, which is widely used as a nutritional supplement. Studies in cells and lower animals show that resveratrol has many potential benefits, including prolonging lifespan, preventing cancer and heart disease and normalization...
What is the current status of trial NCT01375959?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2011-04. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01375959?
The interventions under investigation include: Placebo (DRUG), resveratrol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01375959?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.